Liquid biopsy is demonstrated to be a quick, inexpensive diagnostic modality that can be performed multiple times to help establish a diagnosis of glioblastoma multiforme (GBM) without high-risk neurosurgical interventions.
A 10 or 20 mg/kg daily dose of cannabidiol could almost halve the risk of seizures in children with Dravet syndrome, according to the phase III GWPCARE2* study presented at the American Academy of Neurology annual meeting (AAN 2019).
Use of the antihypertensive drug isradipine did not reduce the progression of Parkinson’s disease, according to the STEADY-PD III* study presented at the American Academy of Neurology annual meeting (AAN 2019).
A novel device for trigeminal nerve stimulation (TNS) effectively improves attention deficit hyperactivity disorder (ADHD) symptoms in children aged 8–12 years, providing a safe nonmedication approach to treating ADHD, a recent study shows.
Treatment with the ROS1 inhibitor entrectinib yielded deep and durable responses in patients with ROS1 fusion-positive non–small cell lung cancer (ROS1+ NSCLC), including in those with brain metastases, according to a pooled analysis of three studies.
Light-intensity physical activity (PA) is associated with higher brain volumes, even among adults who fail to meet the current guidelines of 150 minutes of moderate-to-vigorous PA (MVPA) every week, according to a new study.